Peptides modified by myristoylation activate eNOS in endothelial cells through Akt phosphorylation
- 1 July 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (5) , 732-740
- https://doi.org/10.1038/sj.bjp.0706777
Abstract
Myristoylated pseudosubstrate of PKCζ(mPS) – a synthetic myristoylated peptide with a sequence (13 amino acids) mimicking the endogenous PKCζpseudosubstrate region – is considered a selective cell‐permeable inhibitor of PKCζ. We present strong evidence that in endothelial cells the action of mPS is not limited to inhibition of PKC activity and that myristoylation of certain peptides can activate eNOS (endothelial nitric oxide synthase) through Akt phosphorylation. mPS at micromolar concentrations (1–10 μM) induced profound phosphorylation of eNOS, Akt, ERK 1/2, and p38 MAPK in cultured pulmonary artery endothelial cells (PAEC). The same changes were observed after treatment of PAEC with a myristoylated scrambled version of mPS (mScr), whereas a cell‐permeable version of PKCζpseudosubstrate fused to the HIV‐TAT membrane‐translocating peptide did not induce analogous changes, suggesting that myristoylation confers new properties on the peptides consisting of activation of different signaling pathways in endothelial cells. In addition to mPS and mScr, a number of other myristoylated peptides induced phosphorylation of eNOS suggesting that myristoylation of peptides can activate eNOS by mechanisms unrelated to inhibition of PKC. All active myristoylated peptides contained basic amino acids motif and were longer than six amino acids. Activation of eNOS by myristoylated peptides was dependent on the PI3K/Akt pathway and the rise of intracellular calcium and was associated with an elevation of cGMP levels in PAEC and with relaxation of precontracted isolated pulmonary artery segments. Myristoylated peptides can be considered a new class of activators of NO production in endothelial cells and that using mPS as a specific inhibitor of PKCζshould be done with caution, especially in endothelial cells. British Journal of Pharmacology(2006)148, 732–740. doi:10.1038/sj.bjp.0706777Keywords
This publication has 44 references indexed in Scilit:
- Interaction of a pseudosubstrate peptide of protein kinase C and its myristoylated form with lipid vesicles: Only the myristoylated form translocates into the lipid bilayerBiochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- Activation of Endothelial Nitric-oxide Synthase by the p38 MAPK in Response to Black Tea PolyphenolsJournal of Biological Chemistry, 2004
- Antiviral activity against human immunodeficiency virus-1 in vitro by myristoylated-peptide from Heliothis virescensBiochemical and Biophysical Research Communications, 2004
- Autoinhibitory domain fragment of endothelial NOS enhances pulmonary artery vasorelaxation by the NO-cGMP pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Divergence of Angiogenic and Vascular Permeability Signaling by VEGFArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Bradykinin-regulated Interactions of the Mitogen-activated Protein Kinase Pathway with the Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2000
- Endothelial Proliferation, Migration, and Differentiation Are Blunted by Conditionally Expressed Protein Kinase C Pseudosubstrate PeptidesBiochemical and Biophysical Research Communications, 2000
- Endothelial nitric oxide in humans in health and diseaseInternational Journal of Experimental Pathology, 1999
- Direct evidence of cytoplasmic delivery of PKC‐α, ‐ϵ and ‐ζ pseudosubstrate lipopeptides: study of their implication in the induction of apoptosisFEBS Letters, 1999
- Pseudosubstrate peptide inhibitors of β-cell protein kinases: altered selectivity after myristoylationMolecular and Cellular Endocrinology, 1999